Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments

Decades of pharmacogenetic research have revealed genetic biomarkers of clinical response to antipsychotics. Genetic variants in antipsychotic targets, dopamine and serotonin receptors in particular, and in metabolic enzymes have been associated with the efficacy and toxicity of antipsychotic treatm...

Full description

Bibliographic Details
Main Authors: Marta Hernandez, Natalia Cullell, Marc Cendros, Alexandre Serra-Llovich, Maria J. Arranz
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pharmaceutics
Subjects:
pharmacogenetics
pharmacogenomics
antipsychotics
genetic testing
clinical implementation
Online Access:https://www.mdpi.com/1999-4923/16/2/244

Internet

https://www.mdpi.com/1999-4923/16/2/244

Similar Items